The role of radioactive iodine in the management of patients with differentiated thyroid cancer – An oncologic surgical perspective Review


Authors: Nixon, I. J.; Shah, J. P.; Zafereo, M.; Simo, R. S.; Hay, I. D.; Suárez, C.; Zbären, P.; Rinaldo, A.; Sanabria, A.; Silver, C.; Mäkitie, A.; Vander Poorten, V.; Kowalski, L. P.; Shaha, A. R.; Randolph, G. W.; Ferlito, A.
Review Title: The role of radioactive iodine in the management of patients with differentiated thyroid cancer – An oncologic surgical perspective
Abstract: With improved understanding of the biology of differentiated thyroid carcinoma its management is evolving. The approach to surgery for the primary tumour and elective nodal surgery is moving from a “one-size-fits-all” recommendation to a more personalised approach based on risk group stratification. With this selective approach to initial surgery, the indications for adjuvant radioactive iodine (RAI) therapy are also changing. This selective approach to adjuvant therapy requires understanding by the entire treatment team of the rationale for RAI, the potential for benefit, the limitations of the evidence, and the potential for side-effects. This review considers the evidence base for the benefits of using RAI in the primary and recurrent setting as well as the side-effects and risks from RAI treatment. By considering the pros and cons of adjuvant therapy we present an oncologic surgical perspective on selection of treatment for patients, both following pre-operative diagnostic biopsy and in the setting of a post-operative diagnosis of malignancy. © 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology
Keywords: cancer surgery; review; cancer recurrence; unspecified side effect; cancer patient; risk assessment; radioactive iodine; thyroidectomy; thyroid cancer; adjuvant radiotherapy; radioisotope therapy; adjuvant; differentiated thyroid cancer; human; priority journal
Journal Title: European Journal of Surgical Oncology
Volume: 46
Issue: 5
ISSN: 0748-7983
Publisher: Elsevier Inc.  
Date Published: 2020-05-01
Start Page: 754
End Page: 762
Language: English
DOI: 10.1016/j.ejso.2020.01.010
PUBMED: 31952928
PROVIDER: scopus
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ashok R Shaha
    698 Shaha
  2. Jatin P Shah
    722 Shah